JP2022537521A5 - - Google Patents
Info
- Publication number
- JP2022537521A5 JP2022537521A5 JP2021573829A JP2021573829A JP2022537521A5 JP 2022537521 A5 JP2022537521 A5 JP 2022537521A5 JP 2021573829 A JP2021573829 A JP 2021573829A JP 2021573829 A JP2021573829 A JP 2021573829A JP 2022537521 A5 JP2022537521 A5 JP 2022537521A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- bispecific compound
- pharmaceutically acceptable
- compound according
- stereoisomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962862879P | 2019-06-18 | 2019-06-18 | |
| US62/862,879 | 2019-06-18 | ||
| PCT/US2020/038130 WO2020257278A2 (en) | 2019-06-18 | 2020-06-17 | Small molecule target bromo/acetyl proteins and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022537521A JP2022537521A (ja) | 2022-08-26 |
| JP2022537521A5 true JP2022537521A5 (cg-RX-API-DMAC10.html) | 2023-06-26 |
| JP7626721B2 JP7626721B2 (ja) | 2025-02-04 |
Family
ID=74037322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021573829A Active JP7626721B2 (ja) | 2019-06-18 | 2020-06-17 | 小分子標的ブロモ/アセチルタンパク質およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12496348B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3986470A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP7626721B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN114007652A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2020295399B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3143507A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2020257278A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019371400B2 (en) * | 2018-11-02 | 2024-10-17 | Dana-Farber Cancer Institute, Inc. | Acetylation writer inhibitor development and uses thereof |
| CN117242060B (zh) | 2021-01-13 | 2026-07-17 | 蒙特罗莎治疗股份有限公司 | 异吲哚啉酮化合物 |
| CN114989158A (zh) * | 2021-03-02 | 2022-09-02 | 复旦大学 | 组蛋白乙酰转移酶p300溴结构域抑制剂及其药用组合物及其应用 |
| WO2022257894A1 (zh) * | 2021-06-07 | 2022-12-15 | 贝达药业股份有限公司 | P300抑制剂及其在医药上的应用 |
| CN118359600A (zh) * | 2023-01-17 | 2024-07-19 | 中国科学院广州生物医药与健康研究院 | 一种芳基咪唑基异恶唑类化合物及其制备方法和应用 |
| CN121005703A (zh) * | 2024-05-24 | 2025-11-25 | 中国科学院广州生物医药与健康研究院 | 一种酰胺吲嗪类化合物及其制备方法和应用 |
| CN119707936B (zh) * | 2025-02-25 | 2025-07-25 | 中南大学 | 一种2,4-二取代-5-氟嘧啶衍生物的盐的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105979958A (zh) | 2013-10-11 | 2016-09-28 | 基因泰克公司 | Cbp/ep300布罗莫结构域抑制剂用于癌症免疫疗法的用途 |
| CN107108512B (zh) | 2014-10-10 | 2021-05-04 | 基因泰克公司 | 治疗性化合物及其用途 |
| US9694084B2 (en) * | 2014-12-23 | 2017-07-04 | Dana-Farber Cancer Institute, Inc. | Methods to induce targeted protein degradation through bifunctional molecules |
| JP6815318B2 (ja) | 2014-12-23 | 2021-01-20 | ダナ−ファーバー キャンサー インスティテュート,インコーポレイテッド | 二官能性分子によって標的化タンパク質分解を誘導する方法 |
| GB201506658D0 (en) | 2015-04-20 | 2015-06-03 | Cellcentric Ltd | Pharmaceutical compounds |
| WO2017197046A1 (en) * | 2016-05-10 | 2017-11-16 | C4 Therapeutics, Inc. | C3-carbon linked glutarimide degronimers for target protein degradation |
| EP4717317A3 (en) * | 2017-06-20 | 2026-06-03 | C4 Therapeutics, Inc. | N/o-linked degrons and degronimers for protein degradation |
| MX2020003190A (es) * | 2017-09-22 | 2020-11-11 | Kymera Therapeutics Inc | Degradadores de proteinas y usos de los mismos. |
| AU2019371400B2 (en) * | 2018-11-02 | 2024-10-17 | Dana-Farber Cancer Institute, Inc. | Acetylation writer inhibitor development and uses thereof |
-
2020
- 2020-06-17 EP EP20825420.1A patent/EP3986470A4/en active Pending
- 2020-06-17 CA CA3143507A patent/CA3143507A1/en active Pending
- 2020-06-17 WO PCT/US2020/038130 patent/WO2020257278A2/en not_active Ceased
- 2020-06-17 AU AU2020295399A patent/AU2020295399B2/en active Active
- 2020-06-17 US US17/617,226 patent/US12496348B2/en active Active
- 2020-06-17 CN CN202080044388.9A patent/CN114007652A/zh active Pending
- 2020-06-17 JP JP2021573829A patent/JP7626721B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL278297B2 (en) | Substituted heterocyclic inhibitors of ptpn11 | |
| JP2021511342A5 (cg-RX-API-DMAC10.html) | ||
| ES2750309T3 (es) | Nuevos derivados de arilamida que tienen propiedades antiandrogénicas | |
| JP2018502902A5 (cg-RX-API-DMAC10.html) | ||
| JP2009536620A5 (cg-RX-API-DMAC10.html) | ||
| JP2017528498A5 (cg-RX-API-DMAC10.html) | ||
| CA2448356A1 (en) | N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands | |
| CN109843872A (zh) | 作为ido抑制剂和/或ido-hdac双重抑制剂的多环化合物 | |
| JP2023538524A5 (cg-RX-API-DMAC10.html) | ||
| CN116113416A (zh) | 四环类衍生物、其制备方法和其医药上的用途 | |
| JP2007505044A5 (cg-RX-API-DMAC10.html) | ||
| JP2023513793A5 (cg-RX-API-DMAC10.html) | ||
| EP0676201B1 (en) | Use of a riminophenazine for treating MDR resistance | |
| JP2015512430A (ja) | 癌を治療するための官能性チエノ−インドール誘導体 | |
| JP2025041742A (ja) | 薬学的組合せ | |
| TW201641492A (zh) | 經取代1,2,3-三唑、其用途、以及包含其之醫藥組成物 | |
| JPH01128962A (ja) | 抗新生物剤としてのポリアミン誘導体類 | |
| JPWO2019031614A5 (cg-RX-API-DMAC10.html) | ||
| US20220194930A1 (en) | Matrix Metalloproteinase Inhibitors and Imaging Agents, And Methods Using Same | |
| JP2022502378A5 (cg-RX-API-DMAC10.html) | ||
| CA2504496A1 (en) | N-oxides and derivatives of melphalan for treating diseased states associated with hypoxia inducible factor | |
| JP2005531563A5 (cg-RX-API-DMAC10.html) | ||
| RU2004111787A (ru) | Ретиноидные агонисты (1), производные алкилмочевины | |
| WO2015113521A1 (zh) | 氘代喹唑啉酮化合物以及包含该化合物的药物组合物 | |
| CA2485494A1 (en) | Anti-tumour polycyclic carboxamides |